Highlights From the 2026 Duke fAVS Course

Retina fellows gathered to learn from the experts and gain hands-on wet lab experience.

Emily H. Jung, MD; Naveen Karthik, MD; Haley S. D’Souza, MD, MS; Omar A. Halawa, MD; and Ryan Sameen Meshkin, MD

Beyond the Conventional: A Modified Yamane Technique

This trimmed haptic solution without glued scleral fixation may be beneficial for patients with bilateral aphakia, microcornea, nystagmus, and vitreous opacity.

Supanji Supanji, MD, MSc, PhD; Dewi Fathin Romdhoniyyah, MD, PhD; Aurelia Priscilla Regita Putri, MD; Hifdza Faza Felisha, MD; Vera Nurohmah Indrawati, S.Si; Ummi Noor Hasanah, S.Kep., Ns; Handayani, S.Kep., Ns; Nurul Imawati, MD; Darmawan M. Sophian, MD; Imam Tiharyo, MD, MSc; Mohammad Nafis Sabirin Mara, MD; Firman Setya Wardhana, MD, MSc; and Muhammad Bayu Sasongko, MD, MEPID, PhD

Rare Disease Mystery Cases

Can you diagnose these unusual cases based on the examination and imaging?

Kenneth C. Fan, MD, MBA; Caroline C. Awh, MD; Nimesh A. Patel, MD; Marta Stevanovic, MD, MSc; Maria Emfietzoglou, MD; Demetrios Vavvas, MD, PhD; Mary V. Lang; Lisa A. Schimmenti, MD; Brittni A. Scruggs, MD, PhD; Yicheng Bao, MD; and Hossein Ameri, MD, PhD, FRCSI, MRCOphth

IRD Clinical Trial Endpoints: Lessons Learned

Choosing the right outcome measures for inherited retinal disease trials requires matching endpoints to disease biology, therapeutic mechanism, and patient experience.

Melissa Yuan, MD, and Ahmad Al Moujahed, MD, PhD